Diagnostic Models for Identifying New Cases of Diabetes Mellitus in Patients with Moderate to Severe COVID-19: The Impact of TyG Index, Body Mass Index, and Inflammatory Biomarkers - Takeaways - MDSpire

Diagnostic Models for Identifying New Cases of Diabetes Mellitus in Patients with Moderate to Severe COVID-19: The Impact of TyG Index, Body Mass Index, and Inflammatory Biomarkers

  • By

  • Farzahna Mohamed

  • Sulé Gunter

  • Bezalem E. Yirdaw

  • Frederick J. Raal

  • Aletta M.E Millen

  • Ismail S. Kalla

  • October 30, 2025

  • 0 min

Share

  • 1

    Insulin resistance and obesity are significant risk factors for developing type 2 diabetes mellitus in COVID-19 patients.

  • 2

    The triglyceride-glucose index can enhance diagnostic accuracy for newly diagnosed diabetes when combined with BMI and inflammatory markers.

  • 3

    Elevated BMI is strongly associated with an increased risk of newly diagnosed diabetes in patients recovering from COVID-19.

  • 4

    Cardiometabolic monitoring is essential for COVID-19 survivors, especially those with obesity and insulin resistance risk factors.

  • 5

    Further validation of diabetes prediction models is necessary to effectively estimate risk in vulnerable populations post-COVID-19.

Original Source(s)

Related Content